Skip to content Skip to footer

New lead investor joins PROVIREX

Bioventure joins PROVIREX as a lead investor! IFB Innovationstarter GmbH also increases its investment as a co-investor. These investments will empower further advances in the development of PROVIREX’s technology and build up the necessary infrastructure for research and production in Hamburg.

Read more here.

PROVIREX
Genome Editing Therapies GmbH

Luruper Hauptstraße 1
22547 Hamburg

Germany

mail@provirex.com

Copyright © PROVIREX Genome Editing Therapies GmbH 2023